A growing number of articles in the literature describe experiences using m
ore frequent hemodialysis (HD), either short daily or long nocturnal. Most
of these publications highlight successes obtained by these programs with a
fragmented look at specific areas and outcomes. This review of published r
esults from the use of these therapies shows that universal improvement is
noted in dialysis adequacy, nutrition, quality of life, blood pressure cont
rol, fluid and electrolyte balance, and hospitalizations when these paramet
ers are mentioned. However, data reporting is often incomplete. Most studie
s do not have adequate control groups, patient populations are often differ
ent from the standard HD population, and many have small numbers that precl
ude statistical significance. Nonuniformity of patient selection and study
design prevents accurate comparison and pooling of patient data. In some ca
ses, the same patients' data for the same periods of observation are report
ed in several studies. Despite data that can be characterized as preliminar
y and anecdotal, the results reported in this review show remarkable patien
t improvement worthy of serious consideration by the renal community. To re
ach a level of evidence that will be widely acceptable, the renal community
needs to partner with such government institutions as the National Institu
tes of Health and the Health Care Financing Administration to study systema
tically the outcomes and costs associated with using more frequent HD. In t
he process, important ramifications of such a cooperative study, including
potential changes in policy, need to be considered. (C) 2001 by the Nationa
l Kidney Foundation, Inc.